LORD, ABBETT & CO. LLC – Alnylam Pharmaceuticals, Inc. Transaction History
LORD, ABBETT & CO. LLC portfolio value:
$103.90M
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 519.13K shares | 103.90M | $200.16 | 519.13K |
| Q1 2022 | share | Decrease | -100.00% | -42K shares | -7.12M | $163.29 | 0 |
| Q4 2021 | share | Decrease | -85.00% | -238K shares | -45.74M | $171.03 | 42K |
| Q3 2021 | share | Increase | 0.00% | 280K shares | 52.86M | $188.81 | 280K |
| Q2 2018 | share | Decrease | -100.00% | -297.21K shares | -35.39M | $98.49 | 0 |
| Q1 2018 | share | Increase | +15.74% | 40.40K shares | 2.77M | $119.1 | 297.21K |
| Q4 2017 | share | Increase | +121.86% | 141.05K shares | 19.02M | $127.05 | 256.80K |
| Q3 2017 | share | Increase | 0.00% | 115.75K shares | 13.6M | $117.49 | 115.75K |